Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
36 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
134 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
SME
32 AVENUE DE LA REPUBLIQUE, 94100 ST MAUR DES FOSSES
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Arthritis & rheumatology (Hoboken, N.J.) · 2025
ObjectiveAnti‐synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data‐driven classification criteria for ASSD.MethodsWe used a large, international, multicenter “Classification Criteria for Anti‐synthetase Syndrome” (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort.ResultsOur analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo‐1 and non–Jo‐1 anti‐synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti‐Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD.ConclusionWe identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data‐driven classification criteria for ASSD.image
Frontiers in aging neuroscience · 2023
BackgroundWe aimed to investigate the incidence of dementia by age and year as well as the population-attributable fractions (PAFs) for known dementia risk factors in Republic of Korea.MethodsA 12-year, nationwide, population-based, retrospective cohort study was conducted. We used customized health information from the National Health Insurance Service (NHIS) data from 2002 to 2017. We analyzed age- and sex-adjusted incidence rates and PAF of dementia for each risk factor such as depression, diabetes, hemorrhagic stroke, ischemic stroke, hypertension, osteoporosis and physical inactivity using Levin’s formula.ResultsOf the 794,448 subjects in the dementia-free cohort, 49,524 (6.2%) developed dementia. Dementia incidence showed annual growth from 1.56 per 1,000 person-years in 2006 to 6.94 per 1,000 person-years in 2017. Of all dementia cases, 34,544 subjects (69.8%) were female and 2,479 subjects (5.0%) were early onset dementia. AD dementia accounted for 66.5% of the total dementia incidence. Considering relative risk and prevalence, physical inactivity attributed the greatest to dementia (PAF, 8.1%), followed by diabetes (PAF, 4.2%), and hypertension (PAF, 2.9%). Altogether, the significant risk factors increased the risk of dementia by 18.0% (overall PAF).ConclusionWe provided the incidence of dementia and PAFs for dementia risk factors in Republic of Korea using a 12-year, nationwide cohort. Encouraging lifestyle modifications and more aggressive control of risk factors may effectively prevent dementia.
Rheumatology international · 2022
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Skin health and disease · 2025 · Case Reports
Lim DZJ, Long V, Juay L
Archives of medical research · 2025 · Journal Article
Cho W, Lim DS, Gwon HJ, Abd El-Aty AM, et al.
Archives of Iranian medicine · 2025 · Journal Article
Park KB, Han M, Choi SJ, Park GM, et al.
Arthritis & rheumatology (Hoboken, N.J.) · 2025 · Journal Article
Faghihi-Kashani S, Yoshida A, Bozan F, Zanframundo G, et al.
Journal of thoracic disease · 2025 · Journal Article
Kim JH, Park BY, Choi SH, Kwon HS, et al.
The Korean journal of internal medicine · 2025 · Journal Article
Choi SJ, So MW, Lee S, Choi SW, et al.
Marine drugs · 2024 · Journal Article
Jeong I, Park J, Park S, Wada T, et al.
Journal of the American Academy of Dermatology · 2024 · Journal Article
Kleitsch J, Pandya R, Chakka S, Yan D, et al.
Orthopaedic surgery · 2023 · Case Reports
Oh S, Park HW, Kang SH, Lim D, et al.
Journal of Korean medical science · 2023 · Published Erratum
Kim Y, Ahn E, Lee S, Lim DH, et al.
Bioengineering (Basel, Switzerland) · 2022 · Journal Article
Kwak DS, Kim YD, Cho N, In Y, et al.
Rheumatology international · 2022 · Case Reports
Jeon YH, Lim DH, Choi SW, Choi SJ
Veterinary medicine and science · 2022 · Case Reports
Lim D, Jin Y, Son Y, Oh T, et al.
Biomedicines · 2021 · Journal Article
Lim DH, Lee EJ, Lee HS, Kim DH, et al.
The Korean journal of internal medicine · 2021 · Journal Article
Lim DH, Kim YG, Shim TS, Jo KW, et al.
Scandinavian journal of rheumatology · 2026 · Journal Article
Choi SJ, Lee S, Park S, Park M, et al.
Archives of rheumatology · 2025 · Journal Article
Choi SJ, So MW, Yoo KD, Lee S, et al.
JAAD case reports · 2023 · Case Reports
Pandya R, Lim D, Kleitsch J, Werth VP
Scientific reports · 2024 · Journal Article
Yoon JM, Eun Y, Han K, Kim BS, et al.
European journal of endocrinology · 2023 · Journal Article
Lee J, Jung JH, Kim J, Jeong C, et al.
The Korean journal of internal medicine · 2023 · Journal Article
Oh M, Kim MY, So MW, Lim DH, et al.
Arthritis research & therapy · 2025 · Journal Article
Jun JB, Lee HS, Kim SH, Lee SG, et al.
Internal medicine journal · 2021 · Journal Article
Choi SY, Choi SW, Lee S, So MW, et al.
Journal of clinical medicine · 2023 · Journal Article
Jeong C, Kim J, Lee J, Lim Y, et al.
Journal of clinical medicine · 2023 · Journal Article
Hwang S, Seo M, Lim D, Choi MS, et al.
Therapeutics and clinical risk management · 2026 · Journal Article
Lim DH, Lee CC, Park KB
Asian spine journal · 2026 · Journal Article
Lim DJ, La JI
Immunotherapy · 2021 · Clinical Trial
Nam SH, Lim DH, Heo HM, Oh JS, et al.
The Journal of arthroplasty · 2023 · Randomized Controlled Trial
Sohn S, Koh IJ, Kim MS, Choi KY, et al.
Biochemical and biophysical research communications · 2024 · Journal Article
Ahn SH, Lee YJ, Lim DS, Cho W, et al.
Journal of clinical research in pediatric endocrinology · 2022 · Review
Lim DBN, Moon RJ, Davies JH
Molecules (Basel, Switzerland) · 2022 · Journal Article
Lim DW, Han D, Lee C
Expert opinion on emerging drugs · 2023 · Journal Article
Lim D, Kleitsch J, Werth VP
JAAD case reports · 2023 · Case Reports
Kleitsch J, Lim D, Pandya R, Werth VP
The Journal of rheumatology · 2022 · Journal Article
Kim YE, Choi SJ, Lim DH, Kim H, et al.
Frontiers in aging neuroscience · 2023 · Journal Article
Hwangbo S, Lee JY, Han G, Chun MY, et al.